MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PSI-352938

CAS No. : 1231747-17-3

MCE 站：PSI-352938

产品活性：PSI-352938 (PSI-938) 是一种丙型肝炎病毒 (HCV) 核苷酸抑制剂。

研究领域：Anti-infection

作用靶点：HCV

In Vitro: PSI-352938 (PSI-938) and PSI-353661 inhibit HCV genotype (GT) 1b replicon replication with 50% effective concentrations (EC₅₀s) of 0.13±0.076 μM and 3.0±1.4 nM, respectively, and are similarly active against GT 1a and 2a replicons and infectious viruses. Metabolism of PSI-352938 and PSI-353661 generates the same 5′-triphosphate metabolite, PSI-352666, which is similarly active against NS5B polymerases from GT 1 to 4. PSI-352938 (PSI-938) is a novel cyclic phosphate prodrug of β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methylguanosine 5′-monophosphate that has potent activity against HCV. PSI-352938 (PSI-938) has similar activity against genotype 1a, 1b, and 2a replicons, with EC₅₀s ranging from 0.13 to 0.20 μM and EC₉₀ values ranging from 0.35 to 0.74 μM. PSI-352938 (PSI-938) also effectively inhibits HCV replication in the infectious virus assays: the EC₅₀ and EC₉₀ values are 0.28±0.083 μM and 0.63±0.018 μM, respectively, against the H77 infectious virus and 0.39±0.31 μM and 1.16±0.64 μM, respectively, against the JFH-1 infectious virus. In contrast, PSI-352938 is not active against HBV or HIV up to the highest concentration tested (EC₅₀>100 μM).

相关产品：Resiquimod  |  Honokiol  |  Ribavirin  |  Deferiprone  |  U18666A  |  AG-1478  |  EIDD-1931  |  Artemisinin  |  NIM811  |  Alisporivir  |  Myriocin  |  Mizoribine  |  Merimepodib  |  NHC-triphosphate  |  PSI-7409  |  Peretinoin  |  BLT-1  |  Celgosivir hydrochloride  |  Clemizole hydrochloride  |  Gentiopicroside  |  NM107  |  ITX5061  |  Deapioplatycodin D  |  KIN1408  |  Oglufanide  |  PSI-6130  |  RO-9187  |  RO8191  |  Taribavirin hydrochloride

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。